Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹94 Cr
Revenue (TTM)
₹46 Cr
Net Profit (TTM)
₹4 Cr
ROE
10.6 %
ROCE
14.4 %
P/E Ratio
25.8
P/B Ratio
1.7
Industry P/E
43.17
EV/EBITDA
12
Div. Yield
0 %
Debt to Equity
0
Book Value
₹32.4
EPS
₹2.2
Face value
10
Shares outstanding
16,486,400
CFO
₹13.70 Cr
EBITDA
₹16.04 Cr
Net Profit
₹10.59 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Nephro Care India
| -47.3 | -24.2 | -47.2 | -56.4 | -- | -- | -- |
|
BSE Healthcare
| -4.7 | -5.8 | -5.4 | 1.3 | 23.7 | 14.0 | 10.6 |
|
Company
|
2025
|
|---|---|
|
Nephro Care India
| -42.6 |
|
BSE Small Cap
| -6.6 |
|
BSE Healthcare
| -3.3 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Nephro Care India
|
58.3 | 93.8 | 46.0 | 3.6 | -- | 10.6 | 25.8 | 1.7 |
| 658.1 | 34,224.5 | 4,461.2 | 397.5 | 13.4 | 9.1 | 104.7 | 7.4 | |
| 417.0 | 13,248.9 | 1,976.2 | 160.7 | 14.1 | 6.7 | 105.1 | 6.7 | |
| 527.7 | 7,951.1 | 2,478.2 | 24.7 | 8.4 | 4.2 | 419.6 | 5.9 | |
| 399.6 | 3,653.2 | 1,451.5 | 182.9 | 15.5 | 29.2 | 20 | 5.2 | |
| 1,229.1 | 8,152.5 | 1,433.4 | 188.7 | 17.4 | 13.8 | 43.2 | 5.5 | |
| 5,115.6 | 5,627.0 | 1,529.9 | 235.8 | 21.2 | 20.7 | 23.9 | 4.5 | |
| 197.2 | 8,686.1 | 1,393.6 | 213.2 | -- | 22.1 | 42.3 | 4.6 | |
| 1,149.5 | 11,679.3 | 1,613.3 | 259.9 | 23.0 | 17.3 | 45.3 | 7.3 | |
| 671.6 | 6,528.5 | 1,089.4 | 165.1 | 17.4 | 10.2 | 39 | 3.8 |
No Review & Analysis are available.
--
Incorporated
2014
Chairman
--
Managing Director
Pratim Sengupta
Headquarters
24 Parganas (North), West Bengal
Website
Looking for more details about Nephro Care India Ltd’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
The share price of Nephro Care India Ltd is ₹58.25 (NSE) as of 02-Apr-2026 15:31 IST. Nephro Care India Ltd has given a return of -56.37% in the last 1 years.
The P/E ratio of Nephro Care India Ltd is 25.78 times as on 01-Apr-2026, a 40 discount to its peers’ median range of 43.17 times.
The P/B ratio of Nephro Care India Ltd is 1.74 times as on 01-Apr-2026, a 71 discount to its peers’ median range of 6.10 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
57.61
|
3.92
|
|
2024
|
0.00
|
0.00
|
|
2023
|
0.00
|
0.00
|
|
2022
|
0.00
|
0.00
|
|
2021
|
0.00
|
0.00
|
The 52-week high and low of Nephro Care India Ltd are Rs 183.00 and Rs 50.05 as of 02-Apr-2026.
Nephro Care India Ltd has a market capitalisation of ₹ 94 Cr as on 01-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Nephro Care India Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹1.35
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.